The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients

被引:8
|
作者
Kim, Kwang-Kyoun [1 ,2 ]
Won, Yougun [2 ,3 ]
Won, Ye-Yeon [4 ]
机构
[1] Stanford Univ, Coll Med, Dept Orthoped Surg, Stanford, CA 94305 USA
[2] Konyang Univ, Sch Med, Dept Orthoped Surg, 158 Gwanjeodong Ro, Deajeon 35365, South Korea
[3] Yonsei Univ, Grad Sch Med, Dept Orthopaed, Seoul, South Korea
[4] Ajou Univ, Sch Med, Dept Orthopaed Surg, Suwon, South Korea
关键词
Low molecular weight heparin; deep vein thrombosis; pulmonary embolism; hip fracture; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ORTHOPEDIC-SURGERY; RISK-FACTORS; PROPHYLAXIS;
D O I
10.3349/ymj.2016.57.5.1209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS). Materials and Methods: Prospectively, a total 181 cases were classified into the LMWH user group (116 cases) and LMWH non-user group (65 cases). Each group was sub-classified according to fracture types as follows: 81 cases of intertrochanteric fracture (group A: 49, group B: 32) and 100 cases of neck fracture (group C: 67, group D: 33). We compared the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) according to LMWH use. Results: Of the 181 cases, four DVTs were found in the LMWH user groups (1 in group A, and 3 in group C). One case of PE was found in LMWH non-user group D. The incidences of DVT and PE showed no statistically significant differences between the LMWH user and non-user groups (p=0.298 and 0.359, respectively). In subgroup analysis, no statistically significant differences were found between groups A and B and between groups C and D. Conclusion: The administration of LMWH was not effective in the prevention of venous thromboembolism and PE in the Korean patients who underwent HFS.
引用
收藏
页码:1209 / 1213
页数:5
相关论文
共 50 条
  • [41] Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
    Leer-Salvesen, Sunniva
    Dybvik, Eva
    Dahl, Ola E.
    Gjertsen, Jan-Erik
    Engesaeter, Lars B.
    ACTA ORTHOPAEDICA, 2017, 88 (02) : 236 - 237
  • [42] The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery
    Mahmoudi, Mandana
    Sobieraj, Diana M.
    PHARMACOTHERAPY, 2013, 33 (12): : 1333 - 1340
  • [43] The impact of adopting low-molecular-weight heparin in place of aspirin as routine thromboprophylaxis for patients with hip fracture
    Poacher, Arwel T.
    Hoskins, Hannah C.
    Protty, Majd B.
    Pettit, Rebecca
    Johansen, Antony
    POSTGRADUATE MEDICAL JOURNAL, 2023, 99 (1172) : 582 - 587
  • [44] Aspirin versus low molecular weight heparin for secondary prevention of venous thromboembolism in pregnancy
    Soliman, Reem
    Soliman, Mosaad
    Elsaadany, Nashaat
    Abdelmaksoud, Mohamed A.
    Elkassaby, Mohamed
    EGYPTIAN JOURNAL OF SURGERY, 2025, 44 (01) : 43 - 49
  • [45] Low-molecular-weight heparin: Prophylaxis and treatment of venous thromboembolism
    Pineo, GF
    Hull, RD
    ANNUAL REVIEW OF MEDICINE, 1997, 48 : 79 - 91
  • [46] Lower Mortality and Morbidity with Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Spine Trauma
    Neifert, Sean N.
    Chapman, Emily K.
    Rothrock, Robert J.
    Gilligan, Jeffrey
    Yuk, Frank
    McNeill, Ian T.
    Rasouli, Jonathan J.
    Gal, Jonathan S.
    Caridi, John M.
    SPINE, 2020, 45 (23) : 1613 - 1618
  • [47] Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial
    Kakkar V.V.
    Boeckl O.
    Boneu B.
    Bordenave L.
    Brehm O.A.
    Brücke P.
    Coccheri S.
    Cohen A.T.
    Galland F.
    Haas S.
    Jarrige J.
    Koppenhagen K.
    LeQuerrec A.
    Parraguette E.
    Prandoni P.
    Roder J.D.
    Roos M.
    Rüschemeyer C.
    Siewert J.R.
    Vinazzer H.
    Wenzel E.
    World Journal of Surgery, 1997, 21 (1) : 2 - 9
  • [48] Delayed surgery after hip fracture affects the incidence of venous thromboembolism
    Takuya Taoka
    Takao Ohmori
    Tomoko Kanazawa
    Kazukiyo Toda
    Takeshi Ishihara
    Yasuo Ito
    Journal of Orthopaedic Surgery and Research, 18
  • [49] The Incremental Cost of Inpatient Venous Thromboembolism After Hip Fracture Surgery
    Trivedi, Nikunj N.
    Abola, Matthew, V
    Kim, Chang Y.
    Sivasundaram, Lakshmanan
    Smith, Eric J.
    Ochenjele, George
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2020, 34 (04) : 169 - 173
  • [50] Subcutaneous low-molecular weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients
    Harenberg, J
    Roebruck, P
    Heene, DL
    HAEMOSTASIS, 1996, 26 (03) : 127 - 139